Elon Musk’s Neuralink has initiated the recruitment of subjects for its first human clinical trial, aiming to explore the potential of its creepy brain-computer interface technology that has produced nasty results for unfortunate test monkeys in recent years.
The Verge reports that after securing FDA approval a few months ago, Elon Musk’s Neuralink is stepping into uncharted territories with its six-year initial trial, officially titled “the PRIME Study.” This innovative research is designed to scrutinize Neuralink’s cutting-edge technology, which it believes can empower those suffering from paralysis due to spinal cord injuries or ALS, enabling them to manipulate devices through the interface. Elon Musk, billionaire and chief executive officer of Tesla, at the Viva Tech fair in Paris, France, on Friday, June 16, 2023. Musk predicted his Neuralink Corp. would carry out its first brain implant later this year. Photographer: Nathan Laine/Bloomberg The PRIME […]
Read the Whole Article From the Source: www.breitbart.com
-
Learn the TRUTH about Gold IRAs and how most precious metals companies play dirty.